Research Article

Effects of Aromatherapy on the Anxiety, Vital Signs, and Sleep Quality of Percutaneous Coronary Intervention Patients in Intensive Care Units

Table 1

Homogeneity test for general characteristics.

CategoriesAromatherapy group ( )Control group ( )
(%) (%)

Gender
 Male18 (64.3)24 (85.7)3.43.12*
 Female10 (35.7)4 (14.3)
Age (yr)
 ≤608 (28.6)15 (53.6)3.89.14
 61–7012 (42.8)9 (32.1)
 ≥718 (28.6)4 (14.3)
Marital status
 Unmarried0 (0)1 (3.6)1.021.0*
 Married28 (100)27 (96.4)
Education
 Lower than middle school 21 (75.0)13 (46.4)
 High school6 (21.4)10 (35.7)7.44.11
 More than college1 (3.6)5 (17.9)
Exercise
 Yes6 (21.4)14 (50.0)8.06.09
 No22 (78.6)14 (50.0)
Amount of smoking (cigarettes per day)
 None20 (71.5)18 (64.3)4.08.25
 ≤103 (10.7)2 (7.1)
 ≥10, 203 (10.7)1 (3.6)
 ≥202 (7.1)7 (25.0)
Alcohol consumption
 No20 (71.4)18 (64.3)0.33.57
 Yes8 (28.6)10 (35.7)
Prior PCI
 Yes17 (60.7)17 (60.7).001.0
 No 11 (39.3)11 (39.3)
Site of Insertion
 Wrist site13 (46.4)15 (53.6).29.79
 Femoral site15 (53.6)13 (46.4)
Prior ICU admission
 Yes11 (39.3)11 (39.3)<.0011.0
 No 17 (60.7)17 (60.7)

Mean ± SDMean ± SD P

State anxiety −1.37.17
Trait anxiety 2.0.05
Baseline Anxiety (VAS) −0.43.67
Quality of Sleep 0.79.44
SBP −1.34.86
DBP 0.18.86

: Fisher’s exact test; PCI: Percutaneous coronary intervention; ICU: Intensive Care Unit; Mean ± SD: Mean ± Standard Deviation; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure.